About Us

We are Committed to being a Collaborative Platform for Innovative Biotech Companies from around the World.

Viva BioInnovator ("VBI") is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage, biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential.


Our Advantages

An Innovative Idea is All You Need

portfolio

We invest in some of the most innovative founders to build a unique portfolio covering a wide range of indications and drug types.

  • ABM Therapeutics
  • AceLink Therapeutics
  • AcuraStem
  • AmacaThera
  • Anji Pharma
  • Arthrosi Therapeutics
  • Blue Oak
  • Bright Angel Therapeutics
  • Calira Therapeutics
  • Dogma Therapeutics
  • DTx Pharma
  • Elgia
  • Epican
  • Flash Therapeutics
  • Focus-X
  • Forkhead
  • Eubulus
  • Livati
  • MEBIAS DISCOVERY
  • Mediar Therapeutics
  • MorphoGene
  • NERIO
  • Ophidion
  • Path Therapeutics
  • Phenomic AI
  • Proviva
  • QurAlis Corporation
  • QureBio
  • Regenacy
  • Reglagene
  • Riparian Pharmaceuticals
  • Saverna Therapeutics
  • Seraxis
  • Sisu Pharma
  • Tabomedex Biosciences
  • Technoderma
  • Totient
  • Trio Bio
  • Triumvira
  • United InnoMed
  • VersaPeutics
  • Vincere
  • VivaVision
  • Wei Qing biology
  • XLement

News

Read the most up to date information about us and our partners.